Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors
Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors
This is an observational trial designed to assess prospectively the adherence rate to AIs
 among women with invasive breast cancer (stages I-III) currently receiving AI adjuvant
 therapy after standard local and systemic therapy. We will study adherence by administrating
 the 8-item Morisky Medication Adherence Scale (MMAS - 8).
-  Women with breast cancer seen at the Texas Tech Physicians Breast Care Center will be
 recruited during their routine follow-up visit with their medical oncologist.

 -  Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR)
 invasive breast cancer stages I - III with no evidence of metastatic disease (M0).

 -  Patients must be on one of AI (steroidal or non-steroidal).

 -  Patient must have completed local treatment (surgery /radiation) and recovered from all
 side effects of chemotherapy and surgery.

 -  Patient must be able to complete a demographic and the MMAS - 8 questionnaires in
 English or Spanish.
Inclusion Criteria:

 -  Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR)
 invasive breast cancer stages I - III with no evidence of metastatic disease (M0).

 -  Patient must have completed local treatment (surgery /radiation) and recovered from
 all side effects of chemotherapy and surgery.

 -  Patient must be on one of AI (steroidal or non-steroidal).

 -  Patient must be able to complete a demographic and the MMAS - 8 questionnaires in
 English or Spanish

 Exclusion Criteria:

 -  < 18 years old